Scientific Reports · 2023 · 15 citations · 39 references
Veterinary MedicineInfectious DiseasesClinical EpidemiologyMetabolic PhysiologyRisk Factor AnalysisDiabetes MellitusMetabolic DiseaseMetabolic DisordersMetabolic HealthMetabolic SequelaeMetabolic SyndromeC-reactive Protein TestingMetabolic ComorbidityMetabolic Disease Etiology
Few studies have identified the metabolic consequences of the post-acute phase of nonsevere COVID-19. This prospective study examined metabolic outcomes and associated factors in nonsevere, RT-PCR-confirmed COVID-19. The participants' metabolic parameters, the prevalence of long-term multiple metabolic abnormalities (≥ 2 components), and factors influencing the prevalence were assessed at 1, 3, and 6 months post-onset. Six hundred individuals (mean age 45.5 ± 14.5 years, 61.7% female, 38% high-risk individuals) with nonsevere COVID-19 attended at least one follow-up visit. The prevalence of worsening metabolic abnormalities was 26.0% for BMI, 43.2% for glucose, 40.5% for LDL-c, 19.1% for liver, and 14.8% for C-reactive protein. Except for lipids, metabolic-component abnormalities were more prevalent in high-risk hosts than in healthy individuals. The prevalence of multiple metabolic abnormalities at the 6-month follow-up was 41.3% and significantly higher in high-risk than healthy hosts (49.2% vs 36.5%; P = 0.007). Factors independently associated with a lower risk of these abnormalities were being female, having dyslipidemia, and receiving at least 3 doses of the COVID-19 vaccine. These findings suggest that multiple metabolic abnormalities are the long-term consequences of COVID-19. For both high-risk and healthy individuals with nonsevere COVID-19, healthcare providers should monitor metabolic profiles, encourage healthy behaviors, and ensure complete vaccination.
39
Clinical Characteristics of Coronavirus Disease 2019 in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo, Yongzhen Fan, Ming Chen et al. · JAMA Cardiology · 2020 · 4.3K citations · Full text
Mohammad H. Forouzanfar, Lily Alexander, H Ross Anderson et al. · The Lancet · 2015 · 2.7K citations · Full text
Public Health, Health Sciences, Population Health Sciences +17
Savannah F. Pedersen, Ya‐Chi Ho · Journal of Clinical Investigation · 2020 · 1.2K citations · Full text